Company news

Collegium Pharmaceutical, Inc. news in 2023

Collegium Pharmaceutical, Inc.'s news releases, calls and decks from 2023, newest first.

View company

Appeals Court Upholds PTAB’s Finding of Invalidity of Purdue’s 961 Patent

November 26, 2023

Collegium Reports Third Quarter 2023 Financial Results

November 6, 2023

Collegium to Report Third Quarter 2023 Financial Results on November 7, 2023

October 23, 2023

Collegium Announces 10 Poster Presentations at PAINWeek Conference 2023

August 27, 2023

Collegium Announces Extension of Nucynta Regulatory Exclusivity through July 2026

August 23, 2023

Collegium Announces $50 Million Accelerated Share Repurchase Program

August 6, 2023

Collegium Reports Record 1H’23 Net Revenue of $280.3 Million, Up 35% Year-over-Year

August 2, 2023

Collegium to Report Second Quarter 2023 Financial Results on August 3, 2023

July 19, 2023

Collegium to Participate in Jefferies Healthcare Conference

May 31, 2023

Collegium Reports First Quarter 2023 Financial Results

May 3, 2023

Collegium to Report First Quarter 2023 Financial Results on May 4, 2023

April 19, 2023

Collegium to Participate in 22nd Annual Needham Virtual Healthcare Conference

April 10, 2023

Collegium Reports Fourth Quarter and Full-Year 2022 Financial Results

February 22, 2023

Collegium Pharmaceutical, Inc. Prices Upsized $210.0 Million Convertible Senior Notes Offering

February 6, 2023

Collegium Pharmaceutical, Inc. Announces Proposed Convertible Senior Notes Offering

February 5, 2023

Collegium Announces Fourth Quarter and Full Year 2022 Preliminary Financial Results

February 5, 2023

Collegium Provides 2023 Financial Guidance

January 3, 2023

Calls in 2023

Decks in 2023